ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Glyphic Biotechnologies
Senior Manager / Associate Director of Assay Integration at Glyphic Biotechnologies, leading a team of scientists to develop and integrate assay workflows for single-molecule proteome sequencing.
Headquarters
Berkeley, California, United States
Company Size
11-50 employees
Founded
2021
Glyphic Biotechnologies is a Berkeley, CA-based biotechnology company founded in 2021, developing next-generation protein sequencing technology. Their proprietary Protein Sequencing by Expansion (ProSE™) platform enables de novo, high-throughput proteome sequencing with single-molecule sensitivity, capable of discriminating all 20 amino acids and post-translational modifications (PTMs). Glyphic aims to advance life science discovery by delivering unprecedented precision, scalability, and accessibility in proteomics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Glyphic Biotechnologies.
8% above the average for this role
(Senior) Director of Chemistry
Wing Venture Capital
Staff / Senior Scientist, Assay Development (Library Prep)
Wing Venture Capital
Staff / Senior Scientist, Bioconjugation Chemistry
Wing Venture Capital
Assay Scientist
nautilus biotechnology
Staff/Senior Scientist, Proteomics
Wing Venture Capital
Director, Scientific Operations
Wing Venture Capital